Evidence map›Paper›PMID 24513456›Full record

ReviewBiochimica et biophysica acta2014

Aquaporin and brain diseases.

Jérôme Badaut, Andrew M Fukuda, Amandine Jullienne, Klaus G Petry

Open access · greenAbstract readReview
In one paragraph

Review in Biochimica et biophysica acta, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 207 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Aquaporins in the Capillaries of the Dura Mater of Pigs.International journal of molecular sciences · 2025
    Article
  6. Efficient one-pot radiosynthesis of theEJNMMI radiopharmacy and chemistry · 2025
    Article
  7. Article
  8. Imaging neuroscience (Cambridge, Mass.) · 2025
    Article
  9. bioRxiv : the preprint server for biology · 2024
    Article
  10. Review
  11. Review
  12. Aquaporin Modulation by Cations, a Review.Current issues in molecular biology · 2024
    Review
  13. Review
  14. Aquaporins: Gatekeepers of Fluid Dynamics in Traumatic Brain Injury.International journal of molecular sciences · 2024
    Review
  15. Review
  16. Aquaporins: Potential Targets in Inflammatory Diseases.The Eurasian journal of medicine · 2023
    Article
  17. Article
  18. Review
  19. Biogenic Imaging Contrast Agents.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
  20. Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Jérôme BadautDepartment of Pediatrics, Loma Linda University School of Medicine, Loma Linda, CA 92354, USA; Department of Physiology, Loma Linda University School of Medicine, Loma Linda, CA 92354, USA; Univ Bordeaux, CNRS UMR 5287, 146 rue Leo Saignat33076 Bordeaux cedex. Electronic address: jbadaut@llu.edu.
Andrew M FukudaDepartment of Physiology, Loma Linda University School of Medicine, Loma Linda, CA 92354, USA.
Amandine JullienneDepartment of Pediatrics, Loma Linda University School of Medicine, Loma Linda, CA 92354, USA.
Klaus G PetryINSERM U1049 Neuroinflammation, Imagerie et Thérapie de la Sclérose en Plaques, F-33076 Bordeaux, France.
Loma Linda University · USObservatoire Français de la Sclérose en Plaques · FRUniversité de Bordeaux · FR

Funding

AQP4 and JNK Inhibition Together Reduce Edema and Excitotoxic Injury in jTBIR01HD061946 · NICHD · LOMA LINDA UNIVERSITY · PI ASHWAL, STEPHEN · 2009 to 2013
$1.7M
NICHD NIH HHS R01 HD061946
6 · The paper itself

Abstract

backgroundThe presence of water channel proteins, aquaporins (AQPs), in the brain led to intense research in understanding the underlying roles of each of them under normal conditions and pathological conditions. SCOPE OF REVIEW: In this review, we summarize some of the recent knowledge on the 3 main AQPs (AQP1, AQP4 and AQP9), with a special focus on AQP4, the most abundant AQP in the central nervous system. MAJOR

conclusionsAQP4 was most studied in several brain pathological conditions ranging from acute brain injuries (stroke, traumatic brain injury) to the chronic brain disease with autoimmune neurodegenerative diseases. To date, no specific therapeutic agents have been developed to either inhibit or enhance water flux through these channels. However, experimental results strongly underline the importance of this topic for future investigation. Early inhibition of water channels may have positive effects in prevention of edema formation in brain injuries but at later time points during the course of a disease, AQP is critical for clearance of water from the brain into blood vessels. GENERAL SIGNIFICANCE: Thus, AQPs, and in particular AQP4, have important roles both in the formation and resolution of edema after brain injury. The dual, complex function of these water channel proteins makes them an excellent therapeutic target. This article is part of a Special Issue entitled Aquaporins.

Indexed as

AquaporinsBody WaterBrain DiseasesHumansAquaporinsBlood–brain barrierEdemaNeuroimagingNeuroinflammationNeurovascular unitWater channel

Identifiers

PMID24513456
PMCPMC3960327
OpenAlexW2087556656

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.